Additionally, tumor samples from one patient (Patient #1) were also snap-frozen at the time of collection, allowing for immunoblot analysis, which independently suggested the upregulation of LAPTM4B following the development of EGFR-TKI resistance (Supplementary Fig. S1B). This evidence concerns the gene EGFR and neoplasm.